Dr. Pradeep Kumar, MD, FIAPSM, Professor & Head,

Slides:



Advertisements
Similar presentations
Anti-Malaria Chemotherapy
Advertisements

Javed Sethi. Which type of malarial plasmodium is the most common? What is the incubation period? Is the antimalarial prophylaxis on NHS prescriptions?
Malaria. Malaria is caused by a parasite called Plasmodium, which is transmitted via the bites of infected mosquitoes. In the human body, the parasites.
Doug Simkiss Associate Professor of Child Health Warwick Medical School Management of sick neonates.
Drug Policy Bangladesh Presented by Dr ATM Mustafa Kamal National Programme Manager Malaria and Vector Borne Disease Control DGHS, Dhaka, Bangladesh.
MALARIA TREATMENT PROTOCOL Third edition June 2007 Ministry of Health Republic Democratic of Timor- Leste.
Malaria in Zambia A refresher Scope of Presentation  Background on Malaria  Overview of malaria in Zambia  Interventions  Impact  Active Case.
Malaria Prophylaxis – Travel Medicine Bryan S. Delage MD MC FS SAS North Dakota Air National Guard RSV Training for FS 2013.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 97 Antiprotozoal Drugs I: Antimalarial Agents.
MALARIA History The disease How people get Malaria ( transmission) Symptoms and Diagnosis Treatment Preventive measures Where malaria occurs in the world.
Malaria Prevention Dietsmann HSE Awareness Campaign.
Malaria Dept. of Infectious Disease Shengjing Hospital CMU.
Anti-malarial Drugs Dr Chetna Desai Professor and Head Department of Pharmacology G.M.E.R.S. Medical College, Ahmedabad.
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
Malaria treatment. Dr abdulrahman al shaikh.. Introduction million patients died because of malaria every year. Most deaths due to Plasmodium Falciparum.
Dr Aslesh OP MBBS, MD Assistant professor, community medicine Pariyaram Medical College.
World Health Organization
Management of severe falciparum malaria Dr SK Mishra,MD Ispat General Hospit al, Rourkela India.
Malaria the deadly disease
Malaria Prof. Ahmed A Adeel Malaria Species Four species of malaria : – Plasmodium falciparum: malignant tertian malaria – Plasmodium vivax: benign.
Malaria By: Anish Jaisinghani Date: Period: 3 rd.
Recommendations for Prevention of Malaria
Antimalarial agents Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
T e c h n i c a l S e m i n a r s Malaria Overview Overview Case DefinitionCase Definition Kills Quickly Malaria Risk HighHigh Low How to Assess ClassificationLowHow.
Malaria An Overview of Life-cycle, Morphology and Clinical Picture.
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.

Scientific Method – Case Study How Malaria is Transmitted
Personal Protection Against Malaria avoidance of exposure to mosquitoes at their peak feeding times (usually dusk and dawn) and throughout the night use.
Current National Drug Policies in Lao P.D.R. By Dr Samlane Phompida Centre of Malariology, Parasitology & Entomology.
Malaria Dept. Infectious Disease 2nd Affiliated Hospital CMU.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Dr Zahra Rashid Khan, Assistant Professor, Hematology Department of Pathology.
Taylor Kiyota And Hayley Dardick
Malaria Chemoprophylaxis
SEVERE MALARIA IN CHILDREN-NEW TREATMENT GUIDELINE
Treatment of urinary tract infections
Malaria Diagnosis, Treatment, Prevention. Welcome to Malaria World.
MALARIA. Facts and statistics of malaria About 40% of the world’s population, are at risk of malaria. Of these 2.5 billion people at risk, more than 500.
By anne. * The tropical coast → copious amounts of rain (up to 30 feet). * In the northern → much lower (Drought). South → warmer * West → mountains.
Falciparum Malaria Visit us at :
Relative cost of antimalrial drug
Malaria An Overview of Life-cycle, Morphology and Clinical Picture.
Unit 4 Approaches and Interventions in Pre- Elimination, Elimination and Prevention of Reintroduction Case Management, G6PD, etc and selections of interventions.
Malaria An Overview of Life-cycle, Morphology and Clinical Picture.
Is antimalarial treatment in pregnant women as effective as that in non- pregnant women? Elizabeth Juma, Rashid Aman, Florence Oloo, Bernhards Ogutu Centre.
Global Health Malaria. Transmission Malaria is spread by mosquitoes carrying parasites of the Plasmodium type. Four species of Plasmodium are responsible.
Malaria Chemoprophylaxis and treatment By Mohammed Mahmoud, MD.
Antimalarial Drugs.
Pitfalls in the Diagnosis and Management of malaria Dr Liz Hart.
MALARIA Seema Jain, MS4 6/9/16. BIOLOGY Female Anopheles mosquito is infected with malaria parasites. The mosquito acts as a vector, carrying disease.
Malaria Amal Hassan.
MALARIA By Group 8 (WHO Group)
Malaria in Tribal Areas
Treatment of Malaria Charles Mosler, PharmD, CGP, FASCP
Malaria An Overview of Life-cycle, Morphology and Clinical Picture.
K S Labaran, CPIPP ABU Zaria
Causes of malaria in human Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale.
BY DR WAQAR MBBS, MRCP ASST PROFESSOR
Epidemiology & control of tropical disease
ARULANANDAM TERENCE.T 403(A)
By: Abdul Aziz Timbilla Ahmad Adel Kamil Al-Quraishi
Malaria An Overview of Life-cycle, Morphology and Clinical Picture.
Antiprotozoal Agents Chapter 12. Antiprotozoal Agents Chapter 12.
Chapter 12: Antiprotozoal Agents.
Patient Advice Leaflet for taking Anti-MalarialTablets
Malaria Prevention Dietsmann HSE Awareness Campaign.
Malaria Prophylaxis – Travel Medicine
Pharmacology 3 antimalarial drugs lecture 11 by Prof.Dr. Mohamed Fahmy
Malaria Dr MONA BADR An Overview of Life-cycle, Morphology and
Presentation transcript:

Revised National Drug Policy & Malaria Treatment Guidelines 2010 Min of H & FW, GOI Dr. Pradeep Kumar, MD, FIAPSM, Professor & Head, Community Medicine Dept. GMERS Medical College, Sola, Ahmedabad E mail: drpkumar_55@yahoo.com

Why now?

Introduction Approx. 1.5 million confirmed cases annually (NVBDCP) Pf on (40 - 50%) - due to use of CQ in Rx (resistant?). Non use of PQ Migration 18000 – 20000 die due to malaria every year (underestimates) Curable if treatment started early, any delay may result serious consequences & death.

Resurgence of malaria Increase in migration, urbanization Poverty Complacency in anti malarial programs Deteriorating health system Resistance to insecticides (vectors) & drugs (parasite) Efficient transmission due to increased longevity/ breeding of vectors (global warming)

Clinical features Malaria cardinal symptom – Fever Intermittent (with/ out periodicity) or continuous. Accompanied with chills and rigors. Accompanied by headache, myalgia, arthralgia, anorexia, nausea, vomiting. Suspected when From endemic areas & Presenting with above symptoms. Others include running nose, cough, diarrhea, burning micturition, abdominal pain, ear discharge, Lymphadenopathy

Early diagnosis & treatment (EDT) aims at Complete cure (clinical & parasitological) Prevent progression of uncomplicated malaria to severe (prevent mortality) Prevention of relapse by giving radical treatment Interruption of transmission (prevent new cases by gametocytocidal drugs) Judicious use of drugs to minimize occurrence/ spread of drug resistance.

Microscopy: Thick & thin blood smears Diagnosis Microscopy: Thick & thin blood smears More sensitive & detect parasite at low densities & quantify parasitic load. Also distinguish species & stages Rapid Diagnostic Test (RDT) kits detects Pf/ Pf & P vivax on the basis of circulating parasitic antigens, Ensure – kit kept at recommended temperature, within expiry period & user’s manual adhered FINGER PRICK RDT Kit

Algorithm for diagnosis and treatment of malaria

Algorithm for diagnosis and treatment of malaria

DO YOU KNOW?

Treatment of uncomplicated P. vivax malaria Chloroquine 25 mg/kg divided over 3 days(10 +10+ 5). Primaquine 0.25 mg/kg daily for 14 days. Primaquine contraindicated in Infants Pregnant women & Known G6PD deficient patients - do test if available, Stop PQ if patient develops dark colored urine, yellow conjunctiva, blue discoloration of lips, nausea, vomiting or abdominal pain & report to doctor

Treatment of uncomplicated malaria (P. Vivax) Age Chloroquine (150 mg) Primaquine (2.5 mg) (years) Day 1 Day 2 Day 3 No. of tablets < 1 ½ ¼ Nil 1 – 4 1 5 – 8 2 9 – 14 3 1½ 4 > 15 6 Primaquine given for 14 days in confirmed P vivax Contraindicated in infants, pregnant women & patients with G6PD deficiency

Treatment of uncomplicated malaria P. falciparum All cases confirmed by microscopy/ RDT should get Artemisinin Combination Therapy (ACT) – Artesunate (4 mg/ Kg BW)/ day for 3 days & SP (Sulphadoxine – 25 mg/Kg BW & Pyremethamine 1.25 mg/Kg BW) single dose - day 0 & Primaquine single dose (0.75 mg/kg BW) on 2nd Day. Oral artemisinin monotherapy banned - can lead to drug resistance.

Treatment of uncomplicated malaria (P. falciparum) Age (years) Number of tablets For AS & SP Primaquine (7.5 mg) Day 1 Day 2 Day 3 <1 AS SP ½ ¼ Nil 1 – 4 1 5 – 8 2 1½ 9 – 14 3 4 15 & above 6 AS – Artesunate 50 mg, SP – Sulphadoxine 500 mg + Pyremethamine 25 mg

Treatment of mixed infections Mixed infections with Pf should be treated as falciparum malaria. Anti-relapse treatment with Primaquine to be given for 14 days. Treatment of malaria in pregnancy Pf cases: ACT in 2nd & 3rd trimesters & quinine in 1st trimester (if quinine NA, use ACT). P. vivax treated with Chloroquine in all trimesters. No anti relapse treatment (Primaquine)

General recommendations Avoid treatment on an empty stomach. First dose under observation & repeat if vomiting occurs within 30 minutes. Ask to report back, if no improvement after 48 hrs or situation deteriorates (Not responding to treatment). Also examine for concomitant illnesses.

Chemoprophylaxis Recommended for Travellers to endemic areas, Migrant labourers & Military personnel exposed to highly endemic areas. Chloroquine no longer considered effective for Pf in India; not used for chemoprophylaxis. Pregnancy: It is not recommended now & use of personal protection measures (ITBN, Repellents etc) are encouraged.

Short-term chemoprophylaxis (< 6 weeks) Doxycycline: 100 mg daily in adults and 1.5 mg/kg body weight for children > 8 years old for < 8 years Clindamycin used. Drug is started 2 days before travel & continued for 4 weeks after leaving the malarious area. Contraindicated in pregnant/ lactating women & children < 8 years.

Long-term chemoprophylaxis (> 6 weeks) Mefloquine: 5 mg/kg BW (up to 250 mg) weekly To be taken 2 weeks before, and till 4 weeks after leaving the area. Contraindicated in cases with H/O convulsions, neuropsychiatric and cardiac conditions.

Treatment Failure/ drug resistance: “Cure” if no fever & parasitemia till 28 days otherwise - Treatment Failure/ drug resistance 1. Early treatment failure (ETF) Development of danger signs/ severe malaria on Day 1, 2 or 3, in presence of parasitemia, or Parasitaemia on Day 2 higher than Day 0, irrespective of axillary temperature, or Parasitaemia on Day 3 with axillary temperature > 37.5°C, or Parasitaemia on Day 3, >25% of count on Day 0 irrespective of axillary temperature,

2. Late clinical failure (LCF) Development of danger signs or severe malaria in the presence of parasitaemia on any day between Day 4 and Day 28 (42) or Presence of parasitaemia on any day between Day 4 and Day 28 (42) with axillary temperature > 37.5°C. provided it did not meet criteria of ETF 3. Late parasitological failure (LPF) Presence of parasitemia any day between 7 - 28 Days irrespective of axillary temperature Such cases should get alternative ACT or quinine with Doxy

Severe Malaria & its management

Severe malaria Develops in Pf cases even within 12 hours & may be fatal. Clinical features Impaired consciousness/unrousable coma Repeated generalized convulsions (> 2 in 24 hrs) Prostration (generalized weakness –patient unable walk/sit up without assistance) Renal failure (Serum Creatinine > 3 mg/dl) Clinical Jaundice (Serum Bilirubin > 3 mg/dl) plus evidence of other vital organ dysfunction

Clinical features….cont. Severe Normocytic anaemia (Hb < 5 g/dl or PCV < 15%).) 7. Pulmonary oedema/ ARDS (radiological). 8. Hypoglycaemia (Plasma Glucose < 40 mg/dl) Metabolic acidosis (plasma bicarbonate < 15 mmol/l) Circulatory collapse/shock (SBP <70 mm Hg, <50 mm Hg in children) Abnormal bleeding & DIC

Clinical features….cont. Haemoglobinuria Hyperlactataemia (lactate > 5 mmol/l). Hyperpyrexia (Temperature > 106o F or > 42o C) Hyperparasitaemia (> 5% RBCs parasitized ) Foetal/ maternal complications are more in pregnancy All complication should be managed as acute emergencies along with anti malarial treatment

Severe malaria negative on microscopy May be negative due to low parasitemia, sequestration in vessels & partial treatment Poor microscopy Confirm by RDT or repeat microscopy. Clinical presentation if indicative of severe malaria & no alternative explanation, treat accordingly.

Specific Antimalarials in severe malaria Parenteral artemisinin derivatives or quinine to be used irrespective of Chloroquine sensitivity. Artesunate: 2.4 mg/kg BW, IV/ IM on admission, at 12 hrs & 24 hrs, then once a day (dilute in 5% Soda bi-carb). Artemether: 3.2 mg/kg BW, IM on admission then 1.6 mg/kg BW per day. α−β Arteether: 150 mg daily IM for 3 days in adults (not in children).

Specific Antimalarials of severe malaria cont. Quinine: 20 mg quinine salt/kg BW on admission (IV infusion in 5% dextrose/dextrose saline over 4 hours) followed by maintenance dose of 10 mg/kg BW, 8 hourly; @ 5 mg/kg BW per hour. NEVER GIVE BOLUS INJECTION OF QUININE. If Parenteral quinine continued beyond 48 hours, dose is reduced to 7 mg/kg BW 8 hourly. IV preparations preferred over IM & once started, Parenteral treatment given minimum for 24 hrs.

Once patient take oral therapy – FU treatment Patients receiving Parenteral quinine - treat with oral quinine 10 mg/kg BW 3 times a day to complete course of 7 days, along with Doxycycline 3 mg/ kg BW per day for 7 days. Doxycycline contraindicated in pregnant women/ children < 8 years; instead, Clindamycin 10 mg/kg BW 12 hourly for 7 days used. Severe malaria caused by P. vivax Treated like severe malaria due to Pf.

Think beyond clinical cure While clinical cure achieved with appropriate schizonticidals, gametocytes sucked by vector develop in to disease causing sporozoites which through mosquito bite are again transmitted to healthy person leading to another malaria case. This can be prevented by gametocytocidal drugs (Primaquene)

Take home messages - 1 “Use of gametocytocidal drug should be a part of standard treatment whenever a case is treated”. Use contact with patient/ attendants to give IEC & preventive education for Treatment Prevention of vector bite Collect contact details (address & mobile number) as line list is given to AMC staff to check whether treatment is completed & other measures are taken.

Take home messages - 2 Information of all fever/ malaria cases (IPD or OPD) be collected as per annexure B 5. Any suspected treatment failure should be reported to office of CDMO & PSM Dept. – to be forwarded to RO H & FW (GOI) for study of drug resistance 6. Any death due to malaria be investigated & annexure D must be filled/ reported in consultation with PSM dept.

Thanks